Pharma & Bio
KOSDAQ
Lemon Healthcare Rebounds to Limit-Up on Second Trading Day; D&D Pharmatech and PharmaResearch Also Gain [K-Bio Pulse]
South Korea’s pharmaceutical and biotech sector posted broad gains on Tuesday despite heightened market volatility that triggered a sell-side sidecar on the benchmark stock market early in the session…
KOSDAQ
Lemon Healthcare Sees 'Reversal' Upward on Second Trading Day… D&D Pharmatech Inc. and Pharmaresearch Also Strong [Bio Spotlight]
On the 7th, the domestic pharmaceutical and biotech sector showed an overall upward trend despite significant volatility early in the session, including the activation of the sell-side circuit breaker…
Technology
[In-Depth Look at Genomictree Inc.] ③ 20 Years of Methylation Data… The Next Move Is ‘Therapeutics’
Genomictree Inc.(228760)is known in the market as the developer of “EarlyTec-C,” an early-stage colorectal cancer diagnostic test, and “EarlyTec-B,” an early-stage bladder cancer diagnostic test. Howe…
Technology
[In-Depth Look at Genomictree Inc.] (2) EarlyTech-B Is Not the End… Why “Plus” Is Even More Promising
Genomictree Inc.(228760)’s bladder cancer diagnostic device, EarlyTec-B, obtained a manufacturing license from the Ministry of Food and Drug Safety last January and simultaneously secured CE-IVDR cert…
Technology
[In-Depth Look at Genomictree Inc.] ① A Hail-Mary Move That Sacrificed Blood… 20 Years of Perseverance That Led to the Creation of ‘EarlyTec-C’
The flagship product of Genomictree Inc.(228760), a domestic in vitro molecular diagnostics company, is the “EarlyTec-C,” a device for the early diagnosis of colorectal cancer. Although it received ap…
Technology
Three Strategies to Boost Corporate Value… “Technology Exports, Pet Products, and IPOs” [In-Depth Look at Glasseum ③]
Glasseum is currently known as a company developing treatments for Parkinson’s disease. However, a closer look at the company’s business structure reveals that its strategy is not to stake everything …
Technology
“Alpha-Synuclein Leads to Parkinson’s Disease”…Proposing a Different Solution from Big Pharma [In-Depth Look at Glaseum ②]
The Parkinson’s disease treatment market has been facing the same limitations for decades. Currently available drugs only alleviate symptoms; they do not halt the progression of the disease itself. As…
Technology
“Why Do We Gain Weight as We Age?”… Why CEO Yoo Sang-gu Is Obsessed with Autophagy [In-Depth Look at Glaseum ①]
Obesity and Parkinson’s disease appear to be completely different conditions—one is a metabolic disorder, while the other is a degenerative brain disease. However, Glaseum links these two conditions t…
Technology
3billion Inc.: Will It Strike Gold in Texas? Expectations for a Return to Profitability Next Year
#3billion Inc. has declared next year to be the “first year of revenue growth.” Following a more than twofold increase in operating revenue to 11.7 billion won in 2025 compared to the previous year, t…
Lifestyle
TiumBio Co., Ltd.’s Tosposertib: Why It Can Survive Even the ‘Clinical Graveyard’ of TGF-β
TiumBio Co., Ltd.(321550)Tium Bio appears to be one step closer to becoming “first-in-class” as it accelerates clinical trials of “Tosfosetip,” which works by blocking TGF-β. Although there have been …